Modern problems of interstitial lung diseases in children
https://doi.org/10.21508/1027-4065-2021-66-3-5-11
Abstract
Interstitial lung diseases refer to a large group of diseases with a severe course and unfavorable prognosis, since the most forms of these diseases cause irreversible fibrosis of the lung tissue and severe respiratory failure. Lung transplantation remains the only way to save the patient’s.
The article highlights the current state of the problem, achievements and prospects in the study, diagnosis and approaches to the treatment of interstitial lung diseases in children. The authors emphasize that this direction is one of the most relevant in pediatric pulmonology and clinical medicine in general.
About the Authors
Yu. L. Mizernitskiy
Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
N. S. Lev
Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
References
1. Wijsenbeek M., Kreuter M., Olson A., Fischer A., Bendstrup E., Wells C.D. et al. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin 2019; 35(11): 2015–2024. DOI: 10.1080/03007995.2019.1647040
2. Kolb M., Vašáková M. The natural history of progressive fibrosing interstitial lung diseases. Respir Res 2019; 20(1): 57. DOI: 10.1186/s12931-019-1022-1
3. Wong A.W., Ryerson C.J., Guler S.A. Progression of fibrosing interstitial lung disease. Respir Res 2020; 21(1): 32. DOI: 10.1186/s12931-020-1296-3
4. George P.M., Spagnolo P., Kreuter M., Altinisik G., Bonifazi M., Martinez F.J. et al. ILD working group. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med 2020; 8(9): 925–934. DOI: 10.1016/S2213-2600(20)30355-6
5. Ананьева Л.П., Авдеев С.Н., Тюрин И.Е., Лила А.М., Загребнева А.И., Маслянский А.Л. и др. Хронические фиброзирующие интерстициальные заболевания легких с прогрессирующим фенотипом. Научно-практическая ревматология 2020; 58(6): 631–636. [Anan’eva L.P., Avdeev S.N., Tyurin I.E., Lila A.M., Zagrebneva A.I., Maslyanskij A.L. et al. Chronic fibrosing interstitial lung disease with progressive phenotype. Nauchno-prakticheskaya revmatologiya 2020; 58(6): 631–636]. DOI: 10.47360/1995-4484-2020-631-636
6. Авдеев С.Н., Ананьева Л.П., Жиляев Е.В. Резолюция Совета экспертов, посвященного теме «Интерстициальные заболевания легких при системной склеродермии» (14 октября 2019 г., Москва). Современная ревматология 2020; 14(1): 125–128. [Avdeev S.N., Ananyeva L.P., Zhilyaev E.V. The resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019). Sovremennaya revmatologiya (Modern Rheum) 2020; 14(1): 125–128. (In Russ.) DOI: 10.14412/1996-7012-2020-1-125-128
7. Лев Н.С., Мизерницкий Ю.Л. Клинические варианты интерстициальных болезней легких в детском возрасте. М.: ИД «Медпрактика-М», 2021; 368. [Lev N.S., Mizernickiy Yu.L. Clinical variants of interstitial lung disease in childhood. Moscow: ID «Medpraktika-M», 2021; 368. (In Russ.)]
8. Clement A., Nathan N., Epaud R., Fauroux B., Corvol H. Interstitial lung diseases in children. Orphanet J Rare Dis 2010; 5: 22. DOI: 10.1186/1750-1172-5-22
9. Bush A., Cunningham S., de Blic J., Barbato A., Clement A., Epaud R. et al. European protocols for the diagnosis and initial treatment of interstitial lung disease in children. Thorax 2015; 70(11): 1078–1084. DOI: 10.1136/thoraxjnl-2015-207349
10. Kurland G., Deterding R.R., Hagood J.S., Young L.R., Brody A.S., Castile R.G. et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013; 188(3): 376–394. DOI: 10.1164/rccm201305-0923ST
11. Thacker P.G., Vargas S.O., Fishman M.P., Casey A.M., Lee E.Y. Current Update on Interstitial Lung Disease of Infancy: New Classification System, Diagnostic Evaluation, Imaging Algorithms, Imaging Findings, and Prognosis. Radiol Clin North Am 2016; 54(6): 1065–1076. DOI: 10.1016/j.rcl.2016.05.012
12. Fan L.L., Dishop M.K., Galambos C., Askin F.B., White F.V., Langston C. et al. Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme. Ann Am Thorac Soc 2015; 12(10): 1498–1505. DOI: 10.1513/AnnalsATS.201501-064OC
13. Chanda D., Otoupalova E., Smith S.R., Volckaert T., De Langhe S.P., Thannickal V.J. Developmental pathways in the pathogenesis of lung fibrosis. Mol Aspects Med 2019; 65: 56– 69. DOI: 10.1016/j.mam.2018.08.004
14. Clarke S.L.N., Robertson L., Rice G.I., Seabra L., Hilliard T.N., Crow Y.J. et al. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype. Pediatr Rheumatol 2020; 18: 37. DOI: 10.1186/s12969-020-00425-w
15. Guillerman R.P. Imaging of childhood interstitial lung disease. Pediatr Allergy Immunol Pulmonol 2010; 23(1): 43–68. DOI: 10.1089/ped.2010.0010
16. Walsh S.L.F., Devaraj A., Enghelmayer J.I., Kishi K., Silva R.S., Patel N. et al. Role of imaging in progressive-fibrosing interstitial lung diseases. Eur Resp Revc 2018; 27(150): 180073. DOI: 10.1183/16000617.0073-2018
17. Elicker B.M., Kallianos K.G., Henry T.S. The role of high-resolution computed tomography in the follow-up of diffuse lung disease. Eur Resp Rev 2017; 26(144): 170008. DOI: 10.1183/16000617.0008-2017
18. Liu R., Lei C., Liao X., Shia S., Li J., Hu D. et al. Semi-quantitative analysis for the dynamic chest CT imaging features from onset to recovery in severe and critical COVID-19. Radiol Infect Dis 2020; 7(3): 114–122. DOI: 10.1016/j.jrid.2020.07.003
19. Gorkem S.B., Köse S., Lee E.Y., Doğanay S., Coskun A.S., Köse M. Thoracic MRI evaluation of sarcoidosis in children. Pediatr Pulmonol 2017; 52 (4): 494–499. DOI: 10.1002/ppul.23614
20. Агапитов Л.И., Белозеров Ю.М., Мизерницкий Ю.Л. Хроническое легочное сердце у детей. М.: ГЭОТАР-Медиа, 2014; 152. [Agapitov L.I., Belozerov Yu.M., Mizernickiy Yu.L. Chronic cor pulmonale in children. Moscow: GEOTAR-Media, 2014; 152. (In Russ.)]
21. Bromley S., Vizcaya D. Pulmonary hypertension in childhood interstitial lung disease: A systematic review of the literature. Pediatr Pulmonol 2017; 52(5): 689–698. DOI: 10.1002/ppul.23632
22. Breuer O., Schultz A. Side effects of medications used to treat childhood interstitial lung disease. Paediatr Respir Rev 2018; 28: 68–79. DOI: 10.1016/prrv.2018.03.002
23. Vece T.J., Young L.R. Update on diffuse lung disease in children. Chest 2016; 149(3): 836–845. DOI: 10.1378/chest.15-1986
24. Wells A.U., Flaherty K.R., Brown K.K., Inoue Y., Devaraj A., Richeldi L. et al.; INBUILD trial investigators. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med 2020; 8(5): 453–460. DOI: 10.1016/S2213-2600(20)30036-9
25. Benden C. Pediatric lung transplantation. J Thorac Dis 2017; 9 (8): 2675–2683. DOI: 10.2107/jtd.2017.07.84
26. Goldfarb S.B., Hayes D.Jr., Levvey B.J., Cherikh W.S., Chambers D.C., Khush K.K. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first Pediatric Lung and Heart–Lung Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018; 37(10): 1196–1206. DOI: 10.1016/j.Healun.2018.07.021
27. Лев Н.С., Мизерницкий Ю.Л., Шатоха П.А., Грознова О.С. Трансплантация легких у подростка с легочным фиброзом в исходе интерстициальной болезни легких (гиперсенситивного пневмонита) Педиатрия. Журнал им. Г.Н. Сперанского 2020; 99(6): 287–293. [Lev N.S., Mizernickiy Yu.L., Shatoha P.A., Groznova O.S. Lung transplantation in an adolescent with pulmonary fibrosis as a result of interstitial lung disease (hypersensitive pneumonitis). Pediatriya. Zhurnal im. G.N. Speranskogo 2020; 99(6): 287–293. DOI: 10.24110/0031-403X-2020-99-6-287-293 (In Russ.)]
Review
For citations:
Mizernitskiy Yu.L., Lev N.S. Modern problems of interstitial lung diseases in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2021;66(3):5-11. (In Russ.) https://doi.org/10.21508/1027-4065-2021-66-3-5-11
Views:
887
Email this article 